Search hospitals > New Jersey > Teaneck
Holy Name Medical Center
Claim this profileTeaneck, New Jersey 07666
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Peripheral Arterial Disease
Conducts research for Ovarian Cancer
Conducts research for Ovarian Tumors
140 reported clinical trials
13 medical researchers
Summary
Holy Name Medical Center is a medical facility located in Teaneck, New Jersey. This center is recognized for care of Breast Cancer, Cancer, Peripheral Arterial Disease, Ovarian Cancer, Ovarian Tumors and other specialties. Holy Name Medical Center is involved with conducting 140 clinical trials across 169 conditions. There are 13 research doctors associated with this hospital, such as Yadyra Rivera, Sharyn Lewin, MD, John Rundback, MD, and Jason C. Lee.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
2Cancer
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Yadyra RiveraHoly Name Hospital1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
9 reported clinical trials
16 drugs studied
Sharyn Lewin, MDHoly Name Medical Center2 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
7 reported clinical trials
15 drugs studied
John Rundback, MDHoly Name Medical Center3 years of reported clinical research
Studies Peripheral Arterial Disease
Studies Peripheral Vascular Disease
7 reported clinical trials
9 drugs studied
Jason C. LeeHoly Name Hospital4 years of reported clinical research
Studies Prostate Cancer
Studies Pancreatic Cancer
6 reported clinical trials
25 drugs studied
Clinical Trials running at Holy Name Medical Center
Breast Cancer
Ovarian Cancer
Pancreatic Cancer
Pancreatic Carcinoma
Prostate Cancer
Fallopian Tube Cancer
Recurrence
Cancer
Critical Limb Ischemia
Rectal Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Holy Name Medical Center?
Holy Name Medical Center is a medical facility located in Teaneck, New Jersey. This center is recognized for care of Breast Cancer, Cancer, Peripheral Arterial Disease, Ovarian Cancer, Ovarian Tumors and other specialties. Holy Name Medical Center is involved with conducting 140 clinical trials across 169 conditions. There are 13 research doctors associated with this hospital, such as Yadyra Rivera, Sharyn Lewin, MD, John Rundback, MD, and Jason C. Lee.